Radiotherapy for cancer of the head and neck

Area of Science:

• Radiation Oncology
• Medical Physics
• Oncology

Background:

• Significant progress has been made in head and neck cancer radiotherapy over the last decade.
• Established benchmarks exist for early-stage malignancies, guiding treatment strategies.

Purpose of the Study:

• To review recent advancements in radiotherapy for head and neck cancers.
• To highlight emerging technologies and treatment modalities.
• To discuss the evolving role of multidisciplinary care and clinical trial evaluation.

Main Methods:

• Review of technical advances in accelerators and imaging for precise tumor localization.
• Integration of imaging with computerized treatment planning for optimized radiation dose delivery.
• Evaluation of novel therapeutic approaches including neutron therapy, hyperthermia, radiation sensitizers, and radioprotectors.
• Analysis of dose fractionation schemes, particularly hyperfractionation.
• Assessment of combined surgery and radiotherapy approaches.

Main Results:

• Higher energy accelerators and advanced imaging improve tumor targeting and staging.
• Neutron therapy shows potential for advanced cancers; hyperthermia combined with radiation is promising.
• Hyperfractionation is a clinically promising dose fractionation scheme.
• Combined surgery and radiotherapy improve cure rates, though sequencing remains debated.
• Encouraging progress in radioprotectors for normal tissues.

Conclusions:

• Radiotherapy for head and neck cancer continues to evolve with technological and therapeutic innovations.
• Multidisciplinary collaboration and rigorous clinical trial design are crucial for further progress.
• Optimized radiation delivery, novel combinations, and fractionation schemes enhance treatment efficacy and patient outcomes.